The legislation we introduced is called the Better Pharmaceuticals for Children Act. It is a piece of legislation that we think has great value. According to the American Academy of Pediatrics, only one-fifth, or 20 percent, of all drugs on the market in the United States have been tested for their safety and effectiveness in children. Children are not simply smaller versions of adults. Their bodies actually metabolize drugs quite differently as they grow older. The lack of information about how drugs work in children can place pediatricians in an untenable position. They can either prescribe powerful drugs for their young patients that have only been tested in adults or they can deny them access to life-saving therapies. This dilemma is dramatically illustrated in the case of children with AIDS.
Chris Dodd: “The legislation we introduced is called the Better Pharmaceuticals for Children Act. It is a piece of legislation that…”
Editor's note · Context
Discussing the Better Pharmaceuticals for Children Act and the need for drug testing in children.
Share
More from Chris Dodd
I have frequently been confronted with the extremely difficult necessity of voting for legislation that, while deeply flawed, includes provisions that are incredibly important for the well-being of the American people. Today is no…
I rise today to introduce the Combating Autism Act, CAA, Reauthorization. Six years ago, my former colleague Senator Rick Santorum and I introduced the original CAA to expand Federal investment for Autism research, services, treatment, and…
I rise today to introduce the Garrett Lee Smith Memorial Act, GLSMA, Reauthorization. Six years ago, my former colleague Senator Gordon Smith and I introduced the original GLSMA to address the public health challenge of youth suicide by…
I rise today to pay tribute to a colleague and friend of mine--Senator Evan Bayh--who will be retiring from the U.S. Senate when the 112th Congress convenes in January. I would like to take this moment to thank Evan for his service, and…





